As per the research report, the size of the European Dermatology Diagnostic Devices market was valued at USD 7.90 billion in 2021. It is expected to grow at a CAGR of 7.3% to reach USD 11.23 billion by 2026 during the forecast period 2021 to 2026. It captures 30% of the global market.
Dermatology devices are expected to grow at a faster rate due to rising concern amongst people regarding aesthetics. This has led to rising awareness about various types of aesthetic procedures used for treating hair- and skin-related disorders. Primarily, women suffer from these disorders. Therefore, they are the highest revenue makers in the market.
Increasing the incidence of skin disorders, growing awareness regarding aesthetic procedures, technological advancements, and rising healthcare expenditure are the primary drivers of the market.
This research report on the Europe Dermatology Diagnostic Devices Market has been segmented and sub-segmented into the following categories:
By Type:
By Application:
By Dermatoscopes:
By Country:
The imaging devices category is anticipated to command the largest share of the market during the aforementioned forecast period. It is due to the technological advancements and rising awareness regarding aesthetic procedures. The skin cancer diagnosis segment is expected to account for the largest share of the market during the forecast period.
Key players operating in the Europe Dermatology Diagnostic Devices Market profiled in this report are 3Gen Inc. (U.S.), Bruker Corporation (U.S.), Carl Zeiss (Germany), Genesis Biosystems, Inc. (U.S.), Alma Lasers, Ltd. (Israel), Cutera, Inc. (U.S.), Cynosure, Inc. (U.S.), Lumenis Ltd. (Israel), Valeant Pharmaceuticals (Canada), HEINE Optotechnik GmbH & Co. KG (Germany), Michelson Diagnostics (U.K.), and PhotoMedex, Inc. (U.S.).
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Application
5.1.1 Introduction
5.1.2 Skin Cancer Diagnosis
5.1.3 Other Diagnostic Applications
5.1.4 Y-o-Y Growth Analysis, By Application
5.1.5 Market Attractiveness Analysis, By Application
5.1.6 Market Share Analysis, By Application
5.2 Type
5.2.1 Introduction
5.2.2 Imaging Devices
5.2.3 Dermatoscopes
5.2.4 Microscopes
5.2.5 Y-o-Y Growth Analysis, By Type
5.2.6 Market Attractiveness Analysis, By Type
5.2.7 Market Share Analysis, By Type
5.3 Dermatoscopes
5.3.1 Contact Oil Immersion Dermatoscopes
5.3.2 Cross-Polarized Dermatoscopes
5.3.3 Hybrid Dermatoscopes
5.3.4 Y-o-Y Growth Analysis, By Dermatoscopes
5.3.5 Market Attractiveness Analysis, By Dermatoscopes
5.3.6 Market Share Analysis, By Dermatoscopes
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Application
6.1.3.3 By Type
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Application
6.1.4.3 By Type
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Application
6.1.5.3 By Type
6.2 UK
6.3 France
6.4 Germany
6.5 Italy
6.6 Spain
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Alma Lasers, Ltd.
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Cutera, Inc.
8.3 Cynosure, Inc.
8.4 Lumenis, Ltd.
8.5 Valeant Pharmaceuticals International, Inc.
8.6 3Gen, Inc.
8.7 Bruker Corporation
8.8 Carl Zeiss
8.9 Genesis Biosystems, Inc.
8.10 Heine Optotechnik GmbH & Co. Kg
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
